Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI
Fabian Bohländer(Biotest (Germany)), Stefanie Faust(Biotest (Germany)), Marcus Gutscher(Biotest (Germany)), Dennis Riehl(Johannes Gutenberg University Mainz), Sabrina Weißmüller(Biotest (Germany)), Jörg Schüttrumpf(Biotest (Germany))
Cited by 23
Related Papers
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)
|Intensive Care Medicine|2018|136
The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma
|Clinical Cancer Research|2018|84
Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia
|Clinical Epigenetics|2019|44
A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway
|Immunology and Cell Biology|2014|38
Externalized histones fuel pulmonary fibrosis via a platelet-macrophage circuit of TGFβ1 and IL-27
|Proceedings of the National Academy of Sciences|2023|31